1. Home
  2. KEN vs EVO Comparison

KEN vs EVO Comparison

Compare KEN & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KEN
  • EVO
  • Stock Information
  • Founded
  • KEN 2014
  • EVO 1993
  • Country
  • KEN Singapore
  • EVO Germany
  • Employees
  • KEN N/A
  • EVO N/A
  • Industry
  • KEN Electric Utilities: Central
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • KEN Utilities
  • EVO Health Care
  • Exchange
  • KEN Nasdaq
  • EVO Nasdaq
  • Market Cap
  • KEN 1.8B
  • EVO 1.5B
  • IPO Year
  • KEN N/A
  • EVO 2021
  • Fundamental
  • Price
  • KEN $43.78
  • EVO $4.08
  • Analyst Decision
  • KEN
  • EVO Buy
  • Analyst Count
  • KEN 0
  • EVO 2
  • Target Price
  • KEN N/A
  • EVO $5.90
  • AVG Volume (30 Days)
  • KEN 22.9K
  • EVO 117.0K
  • Earning Date
  • KEN 05-28-2025
  • EVO 08-13-2025
  • Dividend Yield
  • KEN 10.96%
  • EVO N/A
  • EPS Growth
  • KEN N/A
  • EVO N/A
  • EPS
  • KEN 11.35
  • EVO N/A
  • Revenue
  • KEN $760,304,000.00
  • EVO $851,944,444.00
  • Revenue This Year
  • KEN N/A
  • EVO $10.08
  • Revenue Next Year
  • KEN N/A
  • EVO $10.99
  • P/E Ratio
  • KEN $3.79
  • EVO N/A
  • Revenue Growth
  • KEN 5.78
  • EVO 1.50
  • 52 Week Low
  • KEN $23.31
  • EVO $2.84
  • 52 Week High
  • KEN $43.88
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • KEN 83.27
  • EVO 57.98
  • Support Level
  • KEN $42.20
  • EVO $4.15
  • Resistance Level
  • KEN $39.69
  • EVO $4.35
  • Average True Range (ATR)
  • KEN 0.75
  • EVO 0.11
  • MACD
  • KEN 0.55
  • EVO 0.03
  • Stochastic Oscillator
  • KEN 98.93
  • EVO 98.39

About KEN Kenon Holdings Ltd.

Kenon Holdings Ltd is a holding company that operates dynamic, growth-oriented businesses. The company's operating segments include OPC Power Plants, CPV Group, and ZIM. It generates maximum revenue from the OPC Power Plants segment, which generates and supplies electricity and energy in Israel. CPV Group is a limited partnership owned by OPC, which generates and supplies electricity and energy in the United States. Geographically, the company generates a majority of its revenue from Israel and the rest from the United States.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: